Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-05-02 Centrally acting antihypertensive drugs
| Methyldopa |
|
Formulary
|
Tablets 125mg, 250mg, 500mg |
 NG133: Hypertension in pregnancy: diagnosis and management |
|
| Moxonidine |
|
Formulary
|
Tablets 200micrograms, 300micrograms, 400micrograms Reserved for use in resistant hypertension, in line with NG 136 |
|
| Clonidine Hydrochloride |
|
Formulary
|
Tablets 25 microgram Clonidine is considered less suitable for prescribing in hypertension
|
|
LSCMMG: Clonidine 25 mcg tablets - Vasomotor symptoms (VMS) associated with menopause NICE NG136: Hypertension in adults: diagnosis and management |
|
Vasomotor symptoms (VMS) associated with menopauseLinks
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**- Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
- LSCMMG: Atrial Fibrillation
- LSCMMG: Clonidine 25 mcg tablets - Vasomotor symptoms (VMS) associated with menopause
- LSCMMG: Heart Failure - Primary Care Guideline for the Use of SGLT-2 Inhibitors in Reduced Ejection Fraction Heart Failure
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE TA731:Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)